Additionally, high PKM2 expression in intrahepatic cholangiocarcinoma cells enhances resistance to gemcitabine by competitive inhibition of dNTP biosynthesis stimulates gemcitabine incorporation into DNA (52). Here, PKM is linked to intrahepatic cholangiocarcinoma.